Mylan’s Acquisition of Renaissance’s Topicals‑Focused Specialty and Generics Business

On May 13, 2016, Mylan N.V. announced an agreement to acquire the non‑sterile, topicals‑focused specialty and generics business of Renaissance Acquisition Holdings, LLC for $950 million in cash at closing, plus additional contingent payments of up to $50 million, subject to customary adjustments. Cravath is representing Mylan in connection with this transaction.

The Cravath team is led by partners Mark I. Greene and Aaron M. Gruber and includes associates Major C. McCargo and Adam G. DiSimine on M&A matters; partner J. Leonard Teti II and associates Kiran Sheffrin and Arvind Ravichandran on tax matters; partners Eric W. Hilfers and Jonathan J. Katz and associate Matthew J. Bobby on executive compensation and benefits matters; partners Christine A. Varney and Yonatan Even and associates Margaret Segall D’Amico and Allison C. Davido on antitrust matters; partner Matthew Morreale on environmental matters; partner David J. Kappos and practice area attorney Anthony N. Magistrale on intellectual property matters; and practice area attorney Gary R. Eisenman on real estate matters. Brian B. Kennedy is also working on executive compensation and benefits matters.